Phil Kearney

2.5k total citations · 2 hit papers
18 papers, 2.0k citations indexed

About

Phil Kearney is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Phil Kearney has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Phil Kearney's work include Chronic Myeloid Leukemia Treatments (5 papers), Bacterial Genetics and Biotechnology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Phil Kearney is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Bacterial Genetics and Biotechnology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Phil Kearney collaborates with scholars based in Australia, Denmark and United Kingdom. Phil Kearney's co-authors include Maj Hedtjärn, Joacim Elmén, Morten Lindow, Ellen Marie Straarup, Sakari Kauppinen, Henrik F. Hansen, Steven R. Gullans, Peter Sarnow, Susanna Obad and Urs V. Berger and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Phil Kearney

16 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LNA-mediated microRNA silencing in non-human primates

2008 1.3k citations Joacim Elmén, Morten Lindow et al. Nature profile →
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

2007 543 citations Joacim Elmén, Morten Lindow et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phil Kearney Australia	10	1.6k	1.4k	172	105	89	18	2.0k
Jens Bo Hansen Denmark	12	1.2k 0.7×	684 0.5×	228 1.3×	78 0.7×	63 0.7×	17	1.6k
Tammy L. Moser United States	15	949 0.6×	556 0.4×	153 0.9×	97 0.9×	31 0.3×	20	1.5k
Jian Han China	18	1.2k 0.8×	733 0.5×	136 0.8×	51 0.5×	88 1.0×	50	1.6k
Pierluigi Gasparini United States	26	2.0k 1.2×	1.8k 1.3×	209 1.2×	97 0.9×	95 1.1×	46	2.6k
Keiko Shinjo Japan	26	1.6k 1.0×	883 0.6×	162 0.9×	134 1.3×	168 1.9×	55	2.2k
Jill Magnus United States	5	2.4k 1.5×	2.2k 1.5×	126 0.7×	57 0.5×	74 0.8×	5	2.8k
Tiziana Palumbo United States	13	1.6k 1.0×	1.4k 0.9×	197 1.1×	77 0.7×	60 0.7×	17	2.1k
Arianna Bottoni United States	19	1.0k 0.6×	841 0.6×	273 1.6×	106 1.0×	199 2.2×	29	1.7k
Qingwei Zhu China	18	1.5k 0.9×	476 0.3×	231 1.3×	106 1.0×	99 1.1×	39	1.9k
Britta Skawran Germany	19	1.1k 0.7×	689 0.5×	56 0.3×	104 1.0×	74 0.8×	44	1.4k

Countries citing papers authored by Phil Kearney

Since Specialization

Citations

This map shows the geographic impact of Phil Kearney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Kearney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Kearney more than expected).

Fields of papers citing papers by Phil Kearney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Kearney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Kearney. The network helps show where Phil Kearney may publish in the future.

Co-authorship network of co-authors of Phil Kearney

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Kearney. A scholar is included among the top collaborators of Phil Kearney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Kearney. Phil Kearney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tran, Ben, Michael Millward, Charlotte Lemech, et al.. (2023). 1047P AXA-042, a systemically administered TLR2/6 agonist, demonstrates target engagement and TLR pathway activation in patients with advanced solid tumors. Annals of Oncology. 34. S635–S635.

Elmén, Joacim, Morten Lindow, Sylvia Schütz, et al.. (2008). LNA-mediated microRNA silencing in non-human primates. Nature. 452(7189). 896–899. 1307 indexed citations breakdown →

Elmén, Joacim, Morten Lindow, Asli Silahtaroglu, et al.. (2007). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research. 36(4). 1153–1162. 543 indexed citations breakdown →

Westergaard, Majken, Henrik F. Hansen, Charlotte Albæk Thrue, et al.. (2006). SPC2968—A novel Hif-1α antagonist for treatment of clear cell renal cell carcinoma. Journal of Clinical Oncology. 24(18_suppl). 14581–14581. 1 indexed citations

Kearney, Phil, Majken Westergaard, Jens Bo Hansen, et al.. (2005). SPC2996 - A New Bcl-2 Inhibitor for the Treatment of CLL.. Blood. 106(11). 2984–2984. 1 indexed citations

Kearney, Phil, Matteo B. Suter, & J. C. Biggs. (2002). Rapid clonal development in a relapsed CML 11 years post replete allogeneic bone marrow transplantation. Leukemia Research. 26(1). 111–115. 1 indexed citations

Brakebusch, Cord, Simon Fillatreau, Alexandre J. Potocnik, et al.. (2002). β1 Integrin Is Not Essential for Hematopoiesis but Is Necessary for the T Cell-Dependent IgM Antibody Response. Immunity. 16(3). 465–477. 60 indexed citations

Kearney, Phil, et al.. (2001). Current Status of Ribozymes as Gene Therapy Agents for Cancer. Cancer Investigation. 19(5). 495–509. 15 indexed citations

Kearney, Phil, et al.. (1998). Ex Vivo Effects Associated with the Expression of a bcr-abl -Speciftc Ribozyme in a CML Cell Line. Antisense and Nucleic Acid Drug Development. 8(1). 15–23. 13 indexed citations

10.

Kearney, Phil, et al.. (1997). Rapid diagnosis of chronic myeloid leukaemia by linking PCR to capillary gel electrophoresis. Clinical & Laboratory Haematology. 19(4). 261–266. 3 indexed citations

11.

Snowden, John A., et al.. (1997). Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplantation. 20(1). 71–73. 27 indexed citations

12.

Kearney, Phil, et al.. (1995). Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.. PubMed. 23(9). 986–9. 13 indexed citations

13.

Kearney, Phil, et al.. (1993). A Quantitative Polymerase Chain Reaction Assay for Interleukin 5 Messenger RNA. Analytical Biochemistry. 212(1). 50–57. 12 indexed citations

14.

Wilson, S. Brian, et al.. (1993). Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.. PubMed. 21(13). 1714–8. 30 indexed citations

15.

Lyon, B. R., Phil Kearney, Martha Sinclair, & B. W. Holloway. (1988). Comparative Complementation Mapping of Methylophilus spp. Using Cosmid Gene Libraries and Prime Plasmids. Microbiology. 134(1). 123–132. 14 indexed citations

16.

Holloway, B. W., Phil Kearney, & B. R. Lyon. (1987). The molecular genetics of C1 utilizing microorganisms an overview. Antonie van Leeuwenhoek. 53(1). 47–53. 4 indexed citations

17.

Kearney, Phil. (1987). Expression in Escherichia coli and Pseudomonas aeruginosa of Methylophilus methylotrophus AS1 genes carried on prime plasmids. FEMS Microbiology Letters. 44(1). 7–11.

18.

Kearney, Phil & B. W. Holloway. (1987). Expression inEscherichia coliandPseudomonas aeruginosaofMethylophilus methylotrophusAS1 genes carried on prime plasmids. FEMS Microbiology Letters. 44(1). 7–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact